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Abstract 10	
Sponges are known to be a rich source of structurally diverse bioactive natural products, accounting 11	
for approximately one third of the 25,000 novel marine natural products discovered to date. The 12	
advancement of molecular techniques, especially next generation sequencing, has revealed a highly 13	
diverse and complex microbial consortia associated with sponges. Currently, research is on-going to 14	
investigate the role of these microorganisms in symbiosis and in the production of these sponge-15	
associated secondary metabolites. It is hypothesised that adaptations to extreme temperatures and 16	
oxygen levels in the Antarctic may result in novel microbial strains with unprecedented bioactive 17	
metabolites. Although ecological and environmental factors are believed to play a crucial role in the 18	
expression of microbial bioactive secondary metabolites, underpinning the ecological function of 19	
microorganism-sponge interactions within Antarctica is poorly understood, despite mounting 20	
evidence that these metabolites play an important role in chemical defence and microbial community 21	
structure. The importance of the Antarctic ecosystem as a research resource will be underpinned by 22	
future global change; therefore it will be vital for ecological approaches to be addressed in addition to 23	
these biomedical functions. This review collates studies that assess the biomedical activity of 24	
secondary metabolites produced by Antarctic sponge associated microorganisms, which may 25	
stimulate the ecological function to be addressed by the community. 26	
Keywords Biomedical Applications, Secondary Metabolites, Antarctic Sponges, Symbiotic Bacteria, 27	
Antagonism  28	
Introduction 29	
Technological advances over the last decade, in particular next generation sequencing, have revealed 30	
taxonomically diverse microbial consortia associated with sponges, furthermore whole genome 31	
		2	
sequencing has revealed that many of these strains are a rich source of biomedically relevant 32	
secondary metabolites 
1,2
. In recent years, next generation sequencing has provided evidence of 33	
sponge specific bacterial communities, suggesting the possibility that bacteria could be (at least 34	
partly) responsible for some of the bioactive compounds found within their hosts 
3,4
. The biomedical 35	
potential of marine drugs from sponge-derived endosymbionts has been illustrated by many examples 36	
from temperate and tropical waters, including the antibacterial compound quinomycin G which was 37	
produced by a Streptomyces strain isolated from the sponge Gelliodes carnosa 
5
, or eight low-toxicity 38	
diindol-3-ylmethanes with significant antifouling properties 
6
. 39	
Horizontal gene transfer plays a crucial role in bacterial evolution and ecosystem adaptation, which in 40	
turn can alter the biosynthetic ability of the microorganism and therefore the metabolites they produce 41	
7,8
. Horizontal gene transfer has been recognised as a mechanism employed by bacterial to form 42	
resistances against antibiotic compounds, as bacteria can utilise horizontal gene transfer to acquire 43	
antibiotic resistant genes from bacteria belonging to surrounding communities. This increases 44	
biosynthetic diversity, as strains have to continuously adapt to new traits of competitors within the 45	
community 
9,10
 and improve their adaptations to extreme and fast changing environmental conditions 46	
11
. Antarctica is one of the least accessible and most hostile parts of the world, which is partly why 47	
this region remains understudied. Extreme seasonality and temperatures can contribute to high 48	
selective pressures on microorganisms. Antarctic conditions also affect the microbial community 49	
structure associated with sponges as demonstrated by Marconi et al. when they showed sponges 50	
exhibit Antarctic signatures in terms of their microbial community composition 
12
. However, cold-51	
water bacterial symbionts, in particular Antarctic bacteria, have been studied in significantly less 52	
detail. Studies collated in this review demonstrate that these cold-water bacterial symbionts have been 53	
shown to yield a huge potential for the production of novel bioactive secondary metabolites with 54	
bioactivity against medically relevant bacterial strains. For example, Antarctic sponge associated 55	
Psychrobacter, Pseudoalteromonas and Arthrobacter strains have exhibited growth inhibition 56	
towards Burkholderia cepacia complex (Bcc), a consortia of 18 Gram-negative bacterial species 57	
which are pathogenic towards humans and resistant to most common antibiotics 
13,14
. Fungal strains 58	
associated with sponges have also been proven to be a promising source of novel compounds with 59	
high biomedical potential, for example multiple fungal Lindgomycetaceae sp. strains produced two 60	
polyketides (1,2) with significant antibiotic activity against methicillin resistant Staphylococcus 61	
aureus (Figure 1) 
15
. 62	
This review will focus on the biomedical applications of secondary metabolites from microorganisms 63	
associated with Antarctic sponges, highlighting activity against medically relevant strains.  64	
 65	
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 66	
Figure 1. Chemical structures, with isolation source in brackets, of bioactive compounds, including 67	
lingomycin (1) (Lindgomycetaceae sp.), ascosetin (2) (Lindgomycetaceae sp.) and two 68	
diketopiperazines,	cyclo-(L-prolyl-L-tyrosine) (3) and L-tyrosyl-L-valyl-L-prolyl-L-leucine (4) (both 69	
Pseudoalteromonas haloplanktis) 
15,16
. 70	
The Antarctic Ocean Environment 71	
Marine cold-water environments are considered extreme environments, defined as areas exposed to 72	
temperatures below an average of 15 ¡C 
17
. Oceans cover approximately 71% of our planet, with 14% 73	
covered by polar-regions
18
. The major fraction is that of cold-water deep-sea, contributing 90% of the 74	
total ocean volume. Hence, by volume, nearly 85% of EarthÕs biosphere has to be considered a cold-75	
water environment 
8
. The Antarctic Ocean is a high-nutrient low-chlorophyll (HNLC) region which is 76	
constantly exposed to temperatures between +5 ¡C and -2 ¡C. It often remains close to the freezing 77	
point, with average temperatures of −1.9 ¡C throughout the year. The Antarctic Ocean is also 78	
characterised by high oxygen concentrations, which are approximately twofold higher with respect to 79	
water temperatures of 20 ¡C 
19
. Due to sea-ice formation, the Ultraviolet B (UVB) radiation exposure 80	
changes greatly over a year. Microbial abundance is reduced after low levels of winter sea-ice 81	
		4	
formation because of increased exposure to UVB radiation in the subsequent spring 
20
. Furthermore, 82	
formation of sea-ice also leads to brine rejection which has been shown to alter the salinity from 35 ä 83	
to up to 150 ä 
21
. These sea-ice dynamics also enhance mixing of surface waters, providing a 84	
constant nutrient-flux for immobile species 
22
 and the melting of sea-ice, glaciers or terrestrial run-off 85	
contribute to extreme fluctuations in salinity and nutrient content, which can result in osmotic stress 86	
for microorganisms 
23
. 87	
Sponges as Microbial Hosts 88	
Nutrition for sponge communities (which can cover up to 50% of the benthos) can be provided by the  89	
upwelling of Antarctic nutrient rich circumpolar currents 
24
.  These currents can include 90	
taxonomically diverse and chemically rich bacterial species, many of which are indigenous to the 91	
Antarctic environment 
25
. Out of the 436 described Antarctic sponge species reported in an overview 92	
of the ecology of Antarctic marine sponges, 81% belong to the class Demospongiae (352 93	
Demospongiae, 49 Calcarea, 35 Hexactinellida) 
26
. Bacteria find in their host a biotope rich in organic 94	
material including sources of carbon and nitrogen and physical protection. Sponges are therefore a 95	
habitat more favourable than the surrounding seawater but with limited space 
27
. Thus endosymbiotic 96	
microorganisms have to adapt to a high level of competition from both pelagic microorganisms 97	
invading the host and other endosymbionts, which is driving adaptations on a molecular level as well, 98	
leading to the production of various novel secondary metabolites 
28
. Webster et al compared the 99	
bacterial community composition of the Antarctic sponges Kirkpatrickia varialosa, Latrunculia 100	
apicalis, Homaxinella balfourensis, Mycale acerta and Spaerotylus antarcticus as well as seawater 101	
samples using DGGE analysis. They found multiple undescribed archaeal sequences as well as a 102	
broad variety of bacteria, diatoms and dinoflagellates species in communities that were more 103	
consistent with particular host species rather than sampling sites 
1
. The abundance of sponge-104	
associated bacteria has been reported in several studies, and it has been found to vary greatly 105	
depending on sponge species and environmental conditions. In Mediterranean sponges, it was found 106	
that bacteria can account for 40% to 70% of the sponges total volume 
29Ð31
. Antarctic sponges also 107	
host a wide and highly diverse range of microorganisms 
1,12,32
. However, the Antarctic microbial 108	
community changes significantly during an annual cycle due to the extreme seasonality and sea-ice 109	
coverage 
20
. A significant number of microbial populations have also been found to be host specific, 110	
for example, Taylor et al. estimated that approximately 30% of the microbial community within the 111	
Australian sponge Cymbastela concentrica were host-specific 
33
, although not many studies address 112	
sponge-specificity. Observations show that the epibiotic microbial consortium composition of a 113	
particular Antarctic sponge species remained the same regardless of location, whereas microbial 114	
communities from different sponge species in the same location varied substantially 
34
. Hence sponges 115	
are thought to be a microbial ecosystem in their self with complex interactions between microbes and 116	
host 
35
.  117	
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Microbial Adaptations  118	
Low temperature, high oxygen concentration and high UVB exposure can favour the creation of 119	
reactive oxygen species (ROS), which can damage cells and increase oxidative stress 
36,37
. As a 120	
response, Antarctic bacteria such as Pseudoalteromonas haloplanktis have developed specialised 2-121	
on-2 haemoglobins used for resistance against oxidative and nitrosative stress 
38
. In order to withstand 122	
the low temperatures and high oxygen concentration, Antarctic microorganisms have been shown to 123	
produce haemoglobins with enhanced conformational flexibility 
39
. For example, P. haloplanktis has 124	
been shown to increase levels of antioxidant secondary metabolites, oxygen-scavenging enzymes and 125	
alter metabolic pathways, to minimise ROS side products 
40
. In addition, psychrophilic 126	
microorganisms have to cope with extreme temperature-related issues, such as maintenance of protein 127	
function, prevention of cell-freezing and intracellular ice-crystal formation 
7,8
. Bacteria and also fungi, 128	
like Geomyces pannorum, produce high levels of trehalose-sugars, carotenoids, polyols, unsaturated 129	
and polyunsaturated fatty acids to maintain favourable membrane fluidity and permeability 
41Ð44
. 130	
Studies have also revealed exopolysaccharide production in bacteria promotes growth at low 131	
temperatures and high salinity as well as acting as a ligand for micronutrient trace-metals such as iron 132	
45
. Psychrophilic proteins and cold-active enzymes (psychrozymes) are similar in conformation and 133	
3D structure compared to mesophilic homologues, however, psychrozymes often show higher 134	
flexibility especially at active sites due to the reduction of weak intra-cellular bonds 
46
. This enables 135	
higher enzyme efficiency of psychrophiles, compared to temperate-water counterparts, providing 136	
efficient chemical defences in cold environments 
46
. The cold-adapted bacterium Colwellia 137	
psychrerythraea changes its protein homology to enhance enzyme efficiency at low temperatures 
47
. 138	
The concentration of produced metabolites also varies with changing conditions. In a long-term 139	
experiment 16 specimens of the sponge Aplysina aerophoba were analysed in vitro for their 140	
secondary metabolite production. At the beginning and the end of the experiment, they showed 141	
increased concentrations of the major aerophobin compounds, possibly due to cultivation stress 
48
. 142	
The psychrotolerant bacterium Listeria monocytogenes grown at 8 °C and 37 °C also has increased 143	
concentrations of metabolites at low temperature 
49
. 144	
 145	
Utilising Ecological Function as a Source of Novel Biomedicines 146	
Antioxidants  147	
Many psychrophilic microorganisms have evolved to produce compounds that inhibit oxidation of 148	
molecules, thus preventing cell damage. To assess the antioxidant activity the 3-(4,5-149	
dimethylthiazole-2yl)-2,5 diphenyltetrazolium bromide (MTT) method was applied to 101 fungal 150	
		6	
strains of the genus Geomyces isolated from the Antarctic sponges Dendrilla sp., Tedania sp., 151	
Hymeniacidon sp. and Poecilosclerida spp. 
43
. A total of 97 strains (out of 101), showed antioxidant 152	
activity, but only three strains exhibited greater than 60% antioxidant capacity compared with the 153	
negative control. However, the chemical composition of antioxidants in Antarctic microorganisms is 154	
generally unknown with only a few exceptions. Two exocellular diketopiperazines (3, 4) were 155	
extracted from P. haloplanktis (Figure 1) and showed free radical scavenging properties, which was 156	
ascribed to the presence of a phenyl group, when tested in a DPPH free radical-scavenging assay 
16
. 157	
This demonstrates the potential function of diketopiperazines (3, 4) as an antioxidant. Interestingly, 158	
chemically synthesised cyclo-(L-prolyl-L-tyrosine) (3) has also been positively tested as a quorum 159	
sensing molecule with bacterial N-acylhomoserine lactone (AHL) biosensors for Pseudomonas putida 160	
strains 
50
. Considering that the diketopiperazines (3, 4) produced by P. haloplanktis were isolated 161	
from the extracellular supernatant of fermentation broths 
16
, one could argue for the main function of 162	
these compounds to be cell-to-cell communication rather than antioxidant purposes, implying a 163	
double function as well. Another possible explanation could be that the exocellular antioxidants 164	
reduce ROS at the cell surface, thus minimising extracellular ROS, which could otherwise potentially 165	
diffuse through the bacterial cell wall or cause exterior damage to the cell. However, it is clear that 166	
microorganisms are well equipped to withstand high levels of ROS in Antarctic waters and could well 167	
be a prime source for the discovery of novel antioxidants. 168	
Potential adaption mechanisms  169	
Extracts from the sponge Anoxycalyx joubini were found to contain ketosteroid 5α(H)-cholestan-3-170	
one (5) (Figure 2) 
51
. Several Antarctic sponges have been shown to produce ketosteroids, for 171	
example in the Antarctic sponge Haliclona sp. cholesterol and other sterols were surprisingly scarce 172	
or absent compared to the warm water sponge Phyllospongia madagascarensis (with cholesterol as 173	
the main sterol (85.3%)). Instead, several ketosteroid and Δ5-sterol ester derivatives were present such 174	
as cholesta-4,22-dien-3-one (6), cholest-4-en-3-one (7) and 24E-methylcholesta-4,22-dien-3-one (8) 175	
52
. Suggesting the organisms are adapting to the extreme Antarctic conditions by promoting the 176	
production of ketosteroids over cholesterol. Chiang et al. found that dehydrogenases resembling 3-177	
ketosteroid-Δ1-dehydrogenases in P. haloplanktis can produce various derivatives of ketosteroid as a 178	
by-product of the metabolic pathway of cholesterol 
53
. The original 3-ketosteroid-Δ1-dehydrogenase in 179	
P. haloplanktis has since been used to synthesize sterol and ketosteroid catabolites in laboratory 180	
conditions 
54
. P. haloplanktis has been associated with Antarctic sponges in other studies 
55,56
, 181	
therefore it is likely that P. haloplanktis in Antarctic sponges can also produce ketosteroids if 182	
environmental conditions trigger the expression of their encoding biosynthetic gene clusters. 183	
Ketosteroids and cholesterols have biomedical importance as demonstrated for example by Sun et al. 184	
who found promising antibacterial activity of Δ1-3-ketosteroids isolated from warm water 185	
Subergorgio rubra against Bacillus cereus 
57
. In another example Gelzo et al. found that bacterium P. 186	
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haloplanktis produces several catabolites of cholesterol and steroids, which could be potentially useful 187	
for biomedical applications 
54
. 188	
 189	
 190	
   191	
Figure 2. The lipidic 5α(H)-cholestan-3-one (5) extracted from A. joubini; Δ4-3-ketosteroids 192	
extracted from Haliclona sp.; cholesta-4,22-dien-3-one (6); Cholest-4-en-3-one (7); 24E-193	
Methylcholesta-4,22-dien-3-one (8) 
51
. Antimicrobial metabolites isolated from an Antarctic sponge 194	
associated P. aeruginosa (9) phenazine-1-carboxylic acid (10) and phenazine-1-carboxamide. 
58
; the 195	
novel nitroasteric acids pseudogymnoascins A-C (11-14) and 3-nitroasterric acid (14) produced by the 196	
marine fungal strain Pseudogymnoascus sp. F09-T18-1 
59
. 197	
Antagonism among microorganisms 198	
In order to gain an evolutionary advantage many microorganisms produce bioactive compounds to 199	
inhibit the growth of competitors. This can shape the diverse microbial communities in sponges and 200	
influence their highly dynamic interactions 
12
. Many microorganisms, however, produce compounds 201	
to inhibit the growth of microbial competitors; the result is that microorganisms can also develop 202	
resistances against inhibiting compounds, with huge implications in a medical context, i.e. antibiotic 203	
resistant pathogens such as species of the Burkholderia cepacia complex (Bcc) in cystic fibrosis 204	
patients 
60
. The bacterial species P. haloplanktis isolated from the Antarctic sponges Haliclonissa 205	
verrucosa, A. joubini and Lissodendoryx nobilis exhibited almost 100% inhibition against 21 Gram-206	
negative Bcc species in a cross-streaking assay by producing the bioactive volatile organic 207	
compounds (VOCs) identified as benzenamine-N-ethyl and 3-buten-1-ol-3-methyl with the SPME-208	
		8	
GC-MS technique 
55
. Bacterial strains of the genera Arthrobacter, Pseudoalteromonas, Psychrobacter 209	
and Shewanella, isolated from the Antarctic sponges H. verrucosa, A. joubini and L. nobilis, were in 210	
another related study found to be the most predominant and abundant species within the associated 211	
microbial consortia 
14,56
. This may be related to the fact that all of these species were shown to 212	
produce the bioactive and growth inhibiting VOC 3-buten-1-ol-3-methyl 
14,56
. Interestingly, out of 15 213	
bacterial genera, only the aforementioned four were consistently found within all sponges in this 214	
particular study, supporting the hypothesis that VOCs such as 3-buten-1-ol-3-methyl may give the 215	
producing organism an advantage over competitors. Further studies provide evidence for growth 216	
inhibiting VOCs in H. verrucos and L. nobilis produced by Arthrobacter 
61,62
, Psychrobacter 
63
 and 217	
Pseudoalteromonas sp. 
64
; supporting the important role of VOCs as antibacterial secondary 218	
metabolites in Antarctic sponge associated bacteria 
65
. In an ecological context, the production of 219	
VOCs is an energetic expense, thus producing VOCs may give an evolutionary advantage, likely by 220	
suppressing rival species. However, most of the aforementioned studies were using in vitro settings 221	
with known human pathogens as target strains, i.e. Bcc species and has successfully demonstrated that 222	
Antarctic sponge associated bacteria are a promising area for further bioprospecting efforts and 223	
biomedical research on VOCs 
66
.  224	
Research has demonstrated relatively low antagonistic activity in pelagic free-living bacteria for both 225	
temperate waters and Antarctic waters 
67,68
. In one study, only 15% of isolates from Antarctic 226	
seawater exhibited growth inhibition when screened for antagonistic interactions 
70 
. In contrast, 227	
Mangano et al. demonstrated that 90% of cultured Actinobacteria, Bacteroidetes and γ-Proteobacteria, 228	
isolated from the Antarctic sponges A. joubini and L. nobilis (most dominant was the genus 229	
Pseudoalteromonas) showed inhibitory activity towards each other in a cross-niche inhibition assay 230	
69
. However, in vitro communities live in much higher density compared to in situ conditions, 231	
presumably resulting in higher competition, which would suggest an increase in the production of 232	
antimicrobial products. It is well-supported that secondary metabolites produced by sponge associated 233	
symbionts are important for antimicrobial activity 
32
, as demonstrated for both warm water, i.e. α- and 234	
γ-Proteobacteria isolated from Mediterranean sponges 70, and cold-water environments. The bacterium 235	
Pseudoalteromons aeruginosa isolated from the Antarctic sponge Isodictya setifera has been shown 236	
to produce two phenazine alkaloids, phenazine-1-carboxylic acid (9) and phenazine-1-carboxamide 237	
(10) (Figure 2) 
58
. Both compounds showed antimicrobial activity when tested against Bacillus 238	
subtilis, Staphylococcus aureus, and Micrococcus luteus, three gram-positive bacterial species, the 239	
latter two species are very common and potentially pathogenic in humans. Phenazine-1-carboxylic 240	
acid (9) and 1-hydroxyphenazine produced by P. aeruginosa also inhibited growth of the fungus 241	
Fusarium oxysporum (MIC 1 and 2 µg mL
−1
, respectively) , a common potential pathogenic species 242	
towards plants in an agricultural setting 
71
. These examples demonstrate that targeting sponge 243	
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associated symbiotic bacteria may result in a higher antibacterial metabolite discovery rate compared 244	
to low-density open water species.  245	
Fungal symbionts  246	
Although fungal associates of Antarctic sponges have been studied to a lesser degree than their 247	
bacterial counterparts, they comprise an important component of the sponge holobionts, demonstrated 248	
by highly diverse fungal communities that have been found. Out of 101 phenotypically different 249	
fungal strains that were isolated from 11 sponges, 75.2% of isolates belonged to the fungal classes 250	
Leotiomycetes, 12.9% to Dothideomycetes, 7.9% to Eurotiomycetes and 4% to Sordiaromycetes 
43
. 251	
51% out of the 101 isolated strains had growth inhibiting effects on at least one bacterial assay strain, 252	
42.6% showed >50% growth inhibition of which three Geomyces sp. isolates exhibited 100% growth 253	
inhibition of crown gall tumours in a disc bioassay 
43,72
. This shows that there is a high potential for 254	
the discovery of novel compounds for future anti-tumour drugs in sponge symbionts.  255	
The genus Geomycetes (class Leotiomycetes) has been found to be the most common in Antarctic 256	
soil, but interestingly also predominant in Antarctic sponges, with 32.7% of Leotiomycetes strains 257	
belonging to this genus. Pseudogymnoascus sp. isolated from the Antarctic sponge Hymeniacidon sp. 258	
produced four novel nitroasteric acid derivatives (11-14, Figure 2), as well as the previously known 259	
compounds, nitro-diketopiperazine pyriculamide and anthraquinone questin 
59
. However, the 260	
nitroasteric acid derivatives (11-14) showed no significant antibacterial and antifungal activities (MIC 261	
> 64 µg·ml−1). Nonetheless, nitrogen containing compounds with similar structure have been isolated 262	
from the endophytic fungus Coniothyrium sp. and have been shown to exhibit antibacterial, antifungal 263	
and antialgal activity (MIC 1 µg mL
−1
) against Escherichia coli, Microbotryum violaceum and 264	
Chlorella fusca respectively 
73
. The seawater isolated Antarctic fungi Geomyces has also been found 265	
to produce asterric acid derivatives with in vitro antibacterial activity against Gram-positive and 266	
Gram-negative bacteria (IC50 > 50 µM) 74. However, many of these isolated compounds are assayed 267	
against specific medically-relevant target species 
25
, thus, although nitroasteric acids (11-14) did not 268	
show significant bioactivity against strains tested, potent bioactivity of nitroasteric acids (11-14) is 269	
possible against ecologically relevant strains, and nitroasteric acids may serve similar ecological 270	
functions for Pseudogymnoascus sp. as observed from other fungal species, however this has yet to be 271	
confirmed 
59,73,74
. 272	
Biofilm formation  273	
Epibiosis describes the accumulation of non-pathogenic organisms on a biotic surface 
75
. The 274	
antagonistic aspect of epibiosis is often termed biofouling. As reviewed by Wahl et al. the impact of 275	
biofouling in an ecological context for sponges and other sessile filter feeders is mainly the 276	
minimisation of the surface area, hence limiting water flux and nutrient supply 
34
. Microbial 277	
		10	
biofouling is also referred to as biofilm formation, which in a medical context is often associated with 278	
bacterial infections. Many secondary metabolites produced by microorganisms are found to have 279	
antifouling properties 
76
, and often play an ecological role for sponges from Antarctica hosting 280	
microorganisms 
77
.  281	
The  bacterium P. haloplanktis, which has been found in Antarctic sponges as well as the pelagos, 282	
reduces biofilms composed of Staphylococcus epidermidis by 40% over 24 hours suggesting the 283	
presence of a compound with antifouling properties 
78
. This is in line with findings of a similar 284	
experiment by Parilli et al. who also found evidence of anti-biofilm compounds from P. haloplanktis; 285	
after a 96 hour incubation period the collected supernatant of P. haloplanktis cultures reduced the 286	
biofilm formation of S. epidermidis by about 91% 
79
. Diatoms have been shown to colonise the 287	
surface, pores and space in between sponge cells, which can lead to both epi-biofouling and endo-288	
biofouling; therefore, antialgal compounds produced by bacteria, such as nitro-diketopiperazine, could 289	
provide an effective defence against diatoms 
80,81
. Extracts from 25 Antarctic demosponge have been 290	
tested against the diatom Syndroposis sp. and were found to cause high diatom-mortality (60-96%) 
82
.   291	
The same holds true for other sessile filter-feeding species, where the Antarctic sponge species 292	
Alcyonium paessleri and Gersemia antarctica both exhibited strong antifoulant activity against 293	
bacterial biofilm formation and diatom fouling 
83
.These results indicate  a high level of anti-biofouling 294	
compounds in Antarctic sponges 
78,79
. However, the identification of specific compounds and the true 295	
producer of the compounds remains a challenge for future researchers.  296	
Conclusions and Future Direction 297	
Despite logistical and financial challenges associated with studying marine invertebrates in Polar 298	
ecosystems, it is well known that sponges are keystone species in the Antarctic benthic ecosystem and 299	
are associated with highly diverse and abundant microbial communities. These diverse microbial 300	
consortia produce secondary metabolites under extreme Antarctic environmental conditions. This 301	
review has underpinned Antarctic sponge microorganisms as a source of biomedically relevant 302	
metabolites. For these metabolites, occasionally, ecological functions could be speculated. For 303	
example the production of structurally flexible psychrozymes and proteins, may be enforced to cope 304	
with water temperatures remaining close to the freezing point throughout the year, or the production 305	
of diketopiperazine antioxidants by psychrophylic microorganisms may protect against high oxidative 306	
stress due to increased levels of ROS in Antarctic waters. However a community effort is needed to 307	
research the ecological functions of these metabolites to provide further evidence of the 308	
microbiological and ecological importance of Antarctic sponge holobionts. By advancing our 309	
understanding and knowledge in this area, an informed bioprospecting approach would undoubtedly 310	
unveil further novel metabolites with biomedical applications from Antarctic sponge microorganisms. 311	
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